U.S., March 17 -- ClinicalTrials.gov registry received information related to the study (NCT07473713) titled 'Veverimer to Decrease Net Acid Excretion and Bone Resorption in Adults With Osteopenia' on March 10.
Brief Summary: The goal of this clinical trial is to learn if veverimer will reduce urinary net acid excretion leading to reduced bone resorption in healthy adults with osteopenia. The main questions it aims to answer are:
* How much does each dose of veverimer (vs. placebo) reduce 24-hr urinary net acid excretion.
* Describe the safety of veverimer based on changes in serum bicarbonate and potassium.
* Assess the changes in bone resorption.
* Assess the changes in bone formation.
* Explore the effect of veverimer on physical p...